Trial Profile
A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet Age-related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Dexamethasone
- Indications Wet age-related macular degeneration
- Focus Adverse reactions
- Acronyms LuceDex
- 13 Oct 2015 New trial record